Pharmacology Flashcards
1
Q
What are indications for antidepressants?
A
- Unipolar depression
- Organic mood disorders
- Schizoaffective disorders
- Anxiety disorders including GAD, panic disorder, OCD, social phobia, PTSD
- Premenstrual dysphoric disorder
2
Q
What is the length of treatment for antidepressants?
A
- There is a delay, typically of 3-6 weeks after a therapeutic dose is achieved before symptoms improve
- If no improvement is seen after a trial of adequate length (at least 2 months) and adequate dose either switch to another antidepressant or augment with another agent
- When symptoms start to improve/treated, the therapeutic dose needs to be continued up to 6 months after recovery
3
Q
What are the side effects of TCAs?
A
- Lower seizure threshold
- Cardiotoxic - prolong QTc interval, even at therapeutic serum level
- Lethal in overdose
- Anticholinergic effects - dry mouth, blurred vision, constipation, urinary retention, confusion, cognitive/memory problems
- Antiadrenergic effects (alpha 1 + 2 receptors) - postural hypotension, sexual dysfunction, tachycardia
- Antihistaminic effects - sedation, weight gain
4
Q
Describe tertiary TCAs
A
- Act primarily on serotonin receptors
- SEs: antihistaminic (sedation + weight gain), anticholinergic (dry mouth + eyes, constipation, memory deficits + potentially delirium), antiadrenergic (orthostatic hypotension, sedation, sexual dysfunction
- Examples: imipramine, clomipramine, amitriptyline, doxepin
5
Q
Describe secondary TCAs
A
- Act primarily on norepinephrine receipts
- SEs: same as tertiary but generally less severe
- Examples: desipramine, nortriptyline
6
Q
Describe SSRIs
A
- 1st line in anxiety and depression
- Block presynaptic serotonin reuptake
- Very little risk of cardio toxicity in overdose
- SEs: GI upset, sexual dysfunction, anxiety, restlessness, nervousness, insomnia, fatigue, dizziness
- Can develop discontinuation syndrome - agitation, nausea, disequilibrium + dysphoria
- Examples: fluoxetine, sertraline, citalopram, escitalopram, paroxetine
7
Q
Describe SNRIs
A
- If no response to SSRI can switch to an SNRI
- Inhibit both serotonin and norepinephrine reuptake
- Like TCAs but without antihistaminic, antiadrenergic or anticholinergic side effects
- Licensed for both depression and anxiety
- Examples: venlafaxine (also for menopausal symptoms) + duloxetine (also for diabetic neuropathy)
8
Q
Describe MAOIs
A
- Bind to monoamine oxidase thereby preventing inactivation of biogenic amines such as norepinephrine, dopamine and serotonin leading to increased synaptic levels
- Very effective for depression
- SEs: orthostatic hypotension, weight gain, dry mouth, sedation, sexual dysfunction + sleep disturbance
- Hypertensive crisis can develop when MAOIs are taken with tyramine-rich food or sympathomimetics
9
Q
What is serotonin syndrome?
A
Medical emergency due to excessive serotonin
- Autonomic dysfunction: hyperthermia, HTN, hyperreflexia, tachycardia, tremor, agitation, irritability, sweating, diarrhoea, dilated pupils
- Abdo pain, myoclonus, delirium, CV shock + death
10
Q
What is the treatment for serotonin syndrome?
A
- Discontinue medication
- Benzodiazepines for agitation
- Severe - cyproheptadine-serotonin antagonist
- Active cooling
11
Q
What are the indications for mood stabilisers?
A
- Bipolar disorder
- Schizoaffective disorder
- Lithium is also licensed for: prophylaxis + treatment of recurrent unipolar depression and impulse control + treatment of aggressive or self-harming behaviour
12
Q
What are the classes of mood stabilisers?
A
- Lithium
- Anticonvulsants - depakote, lamotrigine, carbamazepine
- Atypical antipsychotics - olanzapine, risperidone, quetiapine, aripiprazole
13
Q
Describe the use of lithium
A
- GOLD STANDARD of mood stabilisers
- Effective in long term prophylaxis of both mania and depressive episodes in >70% of BPAD Type 1 patients
- Factors predicting positive response to lithium: prior long term response or family member with good response, classic pure mania and mania is followed by depression
14
Q
What do you need to check before starting lithium?
A
- Baseline U+Es, TFTs, FBC, weight, BMI + ECG
- Check for pregnancy - teratogenic during 1st trimester, associated with Ebstein’s anomaly
15
Q
What is the monitoring for lithium?
A
- Steady state achieved after 5 days
- Blood sample taken 12hrs after first dose, then after 5 days
- TSH + U+Es 6 monthly
- Then check every week until stable for 4 weeks
- Once stable check 3 monthly